Wednesday, July 8, 2026

pharma · Rheumatoid Arthritis · Calcium

Universal Integrated

Universal Integrated clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

HILLSIDE, NJ, CN HQ
2006 Founded
304 Employees
NMPA registrant Type
Company details
Status
Public
HQ
HILLSIDE, NJ, CN
Founded
2006
Employees
304
Programs
89
Drugs
105
Patents
42
Intelligence · Clinical Programs

Universal Integrated projects

7 ClinicalTrials.gov programs sponsored by Universal Integrated.

Universal Integrated has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. EXT608

    Universal Integrated

    Safety Issues

    phase 1 small molecule completed

    1 trial
  2. Escitalopram

    Universal Integrated

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial
  3. Huafu Shengji Ointment

    Universal Integrated

    Diabetic Foot

    phase 1 small molecule active

    1 trial
  4. Placebo gelatin pill

    Universal Integrated

    Vaginosis, Bacterial

    phase 1 small molecule completed

    1 trial
  5. Western medicine

    Universal Integrated

    Psoriasis

    phase 1 small molecule active

    1 trial
  6. Yiqi Wenyang Sanhan Formula Combined with Acupoint Application

    Universal Integrated

    Allergic Rhinitis With Asthma

    phase 1 small molecule active

    1 trial
  7. autologous FL-33 CAR T therapy

    Universal Integrated

    Refractory/Relapsed Acute Myeloid Leukaemia

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Universal Integrated have?

7 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.